– USA, MA – Profility Inc, a cloud-based, enterprise-grade platform, today announced it has closed a Commercial Round led by Valitas VC alongside existing investors and founders, to accelerate the Go to Market within the US market.
The company also announced the addition of Co-Founder and Managing Partner of Valitas VC, Yaron Itzhari to its Board of Directors
“There is tremendous excitement around Profility and the platform, with a good reason,” said Yaron Itzhari. “They are pointing towards a new fully integrated AI profiling platform with advanced care planning functionality and personalized patient profiles”.
As Co-Founder and Managing Partner of Valitas, Yaron Itzhari is responsible for the venture capital GTM investment strategy and vision. Prior to founding Valitas VC, Previously the Medtronic Israel CEO. Itzhari has 20 years of experience in the pharmaceutical industry and medical technologies. Itzhari founded and was the chairman of the board of the Medtech Association in Israel.
About Profility
Profility provides technology that enables truly personalized care planning, by optimizing decisions and transitions within a healthcare ecosystem. Combining EMR summary techniques with profiling predictive analytics technology, Profility creates a transition profile to support all critical decision points in the discharge process.
The transition profile structures all the UNIQUE CHARACTERISTICS of the patient matches clusters of near-clones, and generates sophisticated estimates for the potential and risks of the patient.
For more information: https://profility.com/
About Valitas
Valitas is a fund which specializes in Healthtech investments. Valitas invests in companies which have completed the scientific feasibility stage and are about to finalize or have finalized the regulatory process. The unique model of the fund is based on the enhancement of these companies by improving the commercialization process.
The VC model ensures the companies a quick and smooth transition from the development process to full commercialization within the US and European markets. The fund is led by managers with rich business experience accumulated in the Health, MedTech, Entrepreneurship, and Capital industries.
- Disclaimer - News, data, and statements included in this release are intended exclusively for general information purposes. Talent4Boards does not guarantee that news is accurate or about the correct person and accepts neither liability for the consequences of the reader’s reliance, nor responsibility for the accuracy of the information. Nothing in this release should be considered for decisions about referred securities. Products and brand names may be trademarks or registered trademarks of their respective owners.
